Phase 2 Start~month

Phase 2 Start: A Randomized Double-Blind Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of

Indication
Antisynthetase Syndrome

Other upcoming events for RNAC

Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Descartes-08 in Patients With Genera

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar